Patient Decision Aid for the Treatment of Actinic Keratosis
Status
Conditions
Treatments
Details and patient eligibility
About
This study evaluates whether a Patient Decision Aid for the field-directed treatment of actinic keratosis has an effect on shared decision making and patient satisfaction.
Full description
Actinic keratosis is the most common epithelial precancerous lesion among the Caucasian race. With an increase in prevalence worldwide due to an aging population and rise of ultraviolet exposure actinic keratosis are among the most frequently encountered skin lesions in clinical practice.
There are many therapeutic modalities for the treatment of actinic keratosis, depending on multiple factors such as distribution, characteristics, patient preference, side effects, availability and costs. Treatment options can be divided into: lesion directed therapy en field directed therapy.
A Patient Decision Aid for field-directed therapies for actinic keratosis may attribute to better shared-decision making and patient satisfaction which on their part may benefits treatment compliance and health outcomes and may lead to fewer disputes between patients and doctors.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- diagnosis actinic keratosis in MaastrichtUMC+ or CatharinaHospital, Eindhoven
- age >18 years
Exclusion criteria
- no knowledge of Dutch language
Trial design
Primary purpose
Allocation
Interventional model
Masking
106 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Klara Mosterd, prof.dr.; Ellen Oyen, drs
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal